Is Kadmon Holdings Inc (KDMN) Stock About to Get Hot Monday?

Monday, November 08, 2021 02:28 PM | InvestorsObserver Analysts

Mentioned in this article

Is Kadmon Holdings Inc (KDMN) Stock About to Get Hot Monday?

The market has been high on Kadmon Holdings Inc (KDMN) stock recently. KDMN gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Kadmon Holdings Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on KDMN!

See Full KDMN Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With KDMN Stock Today?

Kadmon Holdings Inc (KDMN) stock is trading at $9.49 as of 2:26 PM on Monday, Nov 8, a rise of $0.01, or 0.11% from the previous closing price of $9.48. Volume today is light. So far 4,630,896 shares have traded compared to average volume of 7,539,469 shares. The stock has traded between $9.48 and $9.50 so far today. To screen for more stocks like Kadmon Holdings Inc click here.

More About Kadmon Holdings Inc

Kadmon Holdings Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of small molecules and biologics with a focus on inflammatory and fibrotic diseases. Its pipeline products include Belumosudil (KD025) and KD033. Click Here to get the full Stock Report for Kadmon Holdings Inc stock.